{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T01:20:51Z","timestamp":1649035251484},"reference-count":26,"publisher":"Elsevier BV","issue":"50","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.vaccine.2016.10.038","type":"journal-article","created":{"date-parts":[[2016,10,28]],"date-time":"2016-10-28T19:15:37Z","timestamp":1477682137000},"page":"6350-6357","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Use of a booster dose of capsular group C meningococcal glycoconjugate vaccine to demonstrate immunologic memory in children primed with one or two vaccine doses in infancy"],"prefix":"10.1016","volume":"34","author":[{"given":"David","family":"Pace","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ameneh","family":"Khatami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon","family":"Attard-Montalto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Merryn","family":"Voysey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam","family":"Finn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saul N.","family":"Faust","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul T.","family":"Heath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ray","family":"Borrow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew D.","family":"Snape","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew J.","family":"Pollard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2016.10.038_b0005","unstructured":"World Health Organization. Recommendations for the production and control of meningococcal group C conjugate vaccines: WHO Technical Report Series; 2004. p. 924. Annex 2."},{"issue":"6","key":"10.1016\/j.vaccine.2016.10.038_b0010","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1086\/314753","article-title":"Meningococcal serogroup C conjugate vaccine is immunogenic in infancy and primes for memory","volume":"179","author":"Richmond","year":"1999","journal-title":"J Infect Dis"},{"issue":"Suppl.","key":"10.1016\/j.vaccine.2016.10.038_b0015","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1093\/infdis\/136.Supplement.S31","article-title":"Immune Response of human infants of polysaccharide vaccines of group A and C Neisseria meningitidis","volume":"136","author":"Gold","year":"1977","journal-title":"J Infect Dis"},{"issue":"19","key":"10.1016\/j.vaccine.2016.10.038_b0020","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1001\/jama.280.19.1685","article-title":"Induction of immunologic memory by conjugated vs plain meningococcal C polysaccharide vaccine in toddlers: a randomized controlled trial","volume":"280","author":"MacDonald","year":"1998","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.vaccine.2016.10.038_b0025","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1086\/315284","article-title":"Meningococcal C polysaccharide vaccine induces immunologic hyporesponsiveness in adults that is overcome by meningococcal C conjugate vaccine","volume":"181","author":"Richmond","year":"2000","journal-title":"J Infect Dis"},{"issue":"8","key":"10.1016\/j.vaccine.2016.10.038_b0030","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1097\/INF.0b013e3180cc2c25","article-title":"Reconsideration of the use of meningococcal polysaccharide vaccine","volume":"26","author":"Granoff","year":"2007","journal-title":"Pediatr Infect Dis J"},{"issue":"3","key":"10.1016\/j.vaccine.2016.10.038_b0035","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1017\/S0950268899003787","article-title":"Induction of immunological memory in UK infants by a meningococcal A\/C conjugate vaccine","volume":"124","author":"Borrow","year":"2000","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2016.10.038_b0040","unstructured":"World Health Organization (WHO) ECoBS. Proposed replacement of: TRS 926, Annex 3. Part C. Clinical evaluation of group C meningococcal conjugate vaccines; 2007. <http:\/\/www.who.int\/biologicals\/expert_ committee\/BS 2065%20 Mening%20+%20line%20number.pdf> [accessed 30th November 2015]."},{"key":"10.1016\/j.vaccine.2016.10.038_b0045","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.4049\/jimmunol.180.4.2165","article-title":"The magnitude of the antibody and memory B cell responses during priming with a protein-polysaccharide conjugate vaccine in human infants is associated with the persistence of antibody and the intensity of booster response","volume":"180","author":"Blanchard Rohner","year":"2008","journal-title":"J Immunol"},{"issue":"350","key":"10.1016\/j.vaccine.2016.10.038_b0050","doi-asserted-by":"crossref","first-page":"h1554","DOI":"10.1136\/bmj.h1554","article-title":"Immunogenicity of reduced dose priming schedules of serogroup C meningococcal conjugate vaccine followed by booster at 12 months in infants: open label randomised controlled trial","volume":"1","author":"Pace","year":"2015","journal-title":"BMJ"},{"key":"10.1016\/j.vaccine.2016.10.038_b0055","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/j.1365-2567.2008.02934.x","article-title":"Plasma and memory B-cell kinetics in infants following a primary schedule of CRM 197-conjugated serogroup C meningococcal polysaccharide vaccine","volume":"127","author":"Kelly","year":"2009","journal-title":"Immunology"},{"issue":"7","key":"10.1016\/j.vaccine.2016.10.038_b0060","doi-asserted-by":"crossref","first-page":"e101672","DOI":"10.1371\/journal.pone.0101672","article-title":"Evaluation of the induction of immune memory following infant immunisation with serogroup C Neisseria meningitidis conjugate vaccines\u2013exploratory analyses within a randomised controlled trial","volume":"9","author":"Khatami","year":"2014","journal-title":"PLoS ONE"},{"issue":"8","key":"10.1016\/j.vaccine.2016.10.038_b0065","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1128\/CVI.00059-06","article-title":"Early appearance of bactericidal antibodies after polysaccharide challenge of toddlers primed with a group C meningococcal conjugate vaccine: what is its role in the maintenance of protection?","volume":"13","author":"Tsai","year":"2006","journal-title":"Clin Vaccine Immunol"},{"issue":"50","key":"10.1016\/j.vaccine.2016.10.038_b0070","doi-asserted-by":"crossref","first-page":"6974","DOI":"10.1016\/j.vaccine.2009.09.082","article-title":"Kinetics of antibody titres after primary immunization with meningococcal serogroup C conjugate vaccine or secondary immunization with either conjugate or polysaccharide vaccine in adults","volume":"27","author":"de Voer","year":"2009","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.vaccine.2016.10.038_b0075","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1086\/508776","article-title":"Serogroup C meningococcal glycoconjugate vaccine in adolescents: persistence of bactericidal antibodies and kinetics of the immune response to a booster vaccine more than 3 years after immunization","volume":"43","author":"Snape","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"23\u201324","key":"10.1016\/j.vaccine.2016.10.038_b0080","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.1016\/S0264-410X(01)00050-0","article-title":"Comparison of antibody kinetics following meningococcal serogroup C conjugate vaccine between healthy adults previously vaccinated with meningococcal A\/C polysaccharide vaccine and vaccine-na\u00efve controls","volume":"19","author":"Borrow","year":"2001","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2016.10.038_b0085","doi-asserted-by":"crossref","first-page":"e170","DOI":"10.1097\/INF.0b013e318279ac38","article-title":"Antibody persistence and response to a booster dose of a quadrivalent conjugate vaccine for meningococcal disease in adolescents","volume":"32","author":"Jacobson","year":"2013","journal-title":"Pediatr Infect Dis J"},{"issue":"10","key":"10.1016\/j.vaccine.2016.10.038_b0090","doi-asserted-by":"crossref","first-page":"5549","DOI":"10.1128\/IAI.71.10.5549-5555.2003","article-title":"Immunogenicity of, and immunologic memory to, a reduced primary schedule of meningococcal C-tetanus toxoid conjugate vaccine in infants in the United Kingdom","volume":"71","author":"Borrow","year":"2003","journal-title":"Infect Immun"},{"issue":"1 Suppl.","key":"10.1016\/j.vaccine.2016.10.038_b0095","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0163-4453(81)80009-6","article-title":"Meningococcal disease in Belgium. Secondary attack rate among household, day-care nursery and pre-elementary school contacts","volume":"3","author":"De Wals","year":"1981","journal-title":"J Infect"},{"issue":"2","key":"10.1016\/j.vaccine.2016.10.038_b0100","doi-asserted-by":"crossref","first-page":"105","DOI":"10.3109\/inf.1977.9.issue-2.09","article-title":"Immunological investigations of meningococcal disease. III. Brevity of group C acquisition prior to disease occurrence","volume":"9","author":"Edwards","year":"1977","journal-title":"Scand J Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2016.10.038_b0105","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1128\/CVI.00503-10","article-title":"Serum antibody kinetics following nasal or parenteral challenge with meningococcal polysaccharide in healthy adults","volume":"18","author":"Findlow","year":"2011","journal-title":"Clin Vaccine Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2016.10.038_b0110","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1097\/INF.0b013e3181861dba","article-title":"Demonstration of immunologic memory using serogroup C meningococcal glycoconjugate vaccine","volume":"28","author":"Snape","year":"2009","journal-title":"Pediatr Infect Dis J"},{"issue":"9431","key":"10.1016\/j.vaccine.2016.10.038_b0115","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0140-6736(04)16725-1","article-title":"Effectiveness of meningococcal serogroup C conjugate vaccine 4 years after introduction","volume":"364","author":"Trotter","year":"2004","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.vaccine.2016.10.038_b0120","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2807\/esm.09.07.00474-en","article-title":"Impact of the meningococcal C conjugate vaccine in Spain: an epidemiological and microbiological decision","volume":"9","author":"Cano","year":"2004","journal-title":"Euro Surveill"},{"issue":"12","key":"10.1016\/j.vaccine.2016.10.038_b0125","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1086\/509619","article-title":"Clinical and immunologic risk factors for meningococcal C conjugate vaccine failure in the United Kingdom","volume":"194","author":"Auckland","year":"2006","journal-title":"J Infect Dis"},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2016.10.038_b0130","first-page":"S58","article-title":"Planning, registration, and implementation of an immunisation campaign against meningococcal serogroup C disease in the UK: a success story","volume":"20","author":"Miller","year":"2002","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16309732?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16309732?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,15]],"date-time":"2019-09-15T00:19:52Z","timestamp":1568506792000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X16309732"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":26,"journal-issue":{"issue":"50","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["S0264410X16309732"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.10.038","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Use of a booster dose of capsular group C meningococcal glycoconjugate vaccine to demonstrate immunologic memory in children primed with one or two vaccine doses in infancy","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.10.038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}